B-CELL MALIGNANCIES
Clinical trials for B-CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new B-CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for B-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR T-Cell therapy targets Hard-to-Treat blood cancers
Disease control Not yet recruitingThis study tests a new treatment called SHB-02-CD19 for people with certain blood cancers (B-cell malignancies) that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer …
Matched conditions: B-CELL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Double-Pronged CAR t cells take on tough blood cancers
Disease control Not yet recruitingThis early-phase trial tests a new type of CAR T cell therapy that targets two proteins (CD19 and CD20) on cancer cells. It is for adults with B-cell leukemia or lymphoma who have run out of standard treatments, including commercial CAR T cells. The main goal is to check safety a…
Matched conditions: B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New study aims to unlock immune secrets in blood cancers
Knowledge-focused Not yet recruitingThis study looks at two immune receptors, CD85d and CD305, in people with B-cell blood cancers. Researchers want to see how these receptors are expressed in different cancer types and if they can help predict how the disease will progress. The goal is to better understand these c…
Matched conditions: B-CELL MALIGNANCIES
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC